Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (Enzyme panel (Eurofins-Cerep)) EUB0000263b CACNA1S
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (CEREP panel (Eurofins)) EUB0000263b CACNA1S
Inhibition of L-type calcium channel phenylalkylamine site (unknown origin) at 10 uM relative to control
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of calcium channel, Type L (unknown origin) at 10 uM
Ca2+ channel (L, verapamil site) CEREP ligand profiling
Ca2+ channel (L, diltiazem site) CEREP ligand profiling
Ca2+ channel (L, DHP site) CEREP ligand profiling
Ca2+ channel (L, verapamil site) (phenylalkylamines) CEREP ligand profiling
Ca2+ channel (L, diltiazem site) (benzothiazepines) CEREP ligand profiling
Ca2+ channel CEREP ligand profiling
Ca2+ channel (L, dihydropyridine site) CEREP ligand profiling
Ca2+ channel (L verapamil site) Ligand binding assay
Inhibition of L type calcium channel (unknown origin) at 10 uM
Assay data:2 Tested
Inhibition of calcium channel, Type L (unknown origin) at 0.1 to 1 uM
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on